"/> Tocris Bioscience™ ICG 001 | B-LABO France

Tocris Bioscience™ ICG 001

Réf. : BL-RE-126072Réf. fabricant : 18035112 50 mg
1 334,64 € HT

Inhibits TCF/β-catenin-mediated transcription

Nom chimique ou matériau
(6S,9aS)-Hexahydro-6-[(4-hydroxyphenyl)methyl]-8-(1-naphthalenylmethyl)-4,7-dioxo-N-(phenylmethyl)-2H-pyrazino[1,2-a]pyrimidine-1(6H)-carboxamide
CAS
780757-88-2
Quantité
50 mg
Cible
beta-Catenin Inhibitors
Formule moléculaire
C33H32N4O4
Marque
Tocris Bioscience

ICG 001 is an inhibitor of TCF/β-catenin-mediated transcription. Selectively inhibits β-catenin/CBP interaction; displays no effect on β-catenin/p300 interaction. Exhibits growth inhibitory effects in colon carcinoma cell lines (SW480 and HCT-116 cells); also displays efficacy in Min mouse and nude mouse SW620 xenograft models.

Caractéristiques techniques

MarqueTocris Bioscience
Réf. B-LABOBL-RE-126072
Réf. fabricant18035112
Nom chimique ou matériau(6S,9aS)-Hexahydro-6-[(4-hydroxyphenyl)methyl]-8-(1-naphthalenylmethyl)-4,7-dioxo-N-(phenylmethyl)-2H-pyrazino[1,2-a]pyrimidine-1(6H)-carboxamide
CAS780757-88-2
Quantité50 mg
Ciblebeta-Catenin Inhibitors
Formule moléculaireC<sub>33</sub>H<sub>32</sub>N<sub>4</sub>O<sub>4</sub>
Pureté0.98
Une question, une configuration particulière ?
Contactez-nous pour un devis.